Clinical Trials
임상시험 트래커
국내사는 전체 임상 이력, 글로벌 메이저는 진행 중 파이프라인을 추적합니다. ClinicalTrials.gov API v2에서 6시간 주기로 수집합니다.
기업
34 results
- 1상모집 중· HIV -1 InfectionHIV 감염 여부와 관계없는 성인에서 RNA 기반 백신 BNT168의 안전성 및 면역 반응 평가 임상시험
A Clinical Trial to Look at the Safety and Immune Responses of the RNA-based Vaccine BNT168 in Adults Living With or Without HIV
리드: 바이오엔테크
- 4상모집 중· COVID-19 Vaccines18-64세 건강한 성인에서 COVID-19 백신에 대한 연구
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age
리드: 바이오엔테크 · 협력: 화이자
- 3상모집 중· Metastatic Castration-resistant Prostate Cancer전이성 거세 저항성 전립선암에서 BNT324과 도세탁셀의 3상 시험
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
리드: 바이오엔테크
- 1/2상모집 중· Advanced Solid Tumor Cancer진행성 고형 종양 환자를 대상으로 BNT3214의 안전성 및 초기 효능을 평가하는 조기임상시험
Early-phase Trial to Assess the Safety and Preliminary Efficacy of BNT3214 in Adults With Advanced Solid Tumors
리드: 바이오엔테크
- 1/2상모집 중· Advanced Renal Cell Carcinoma (RCC)진행성 신세포암종(RCC) 환자에서 푸미타미그 단독 또는 다른 제제와의 병용 투여의 안전성, 내약성 및 유효성을 평가하는 연구(ROSETTA RCC-208)
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
리드: BMS · 협력: 바이오엔테크
- 3상모집 중· Non-small Cell Lung Cancer (NSCLC)절제 불가능한 3기 비소세포폐암(NSCLC) 환자에서 동시 화학방사선 치료 후 푸미타미그 대 두르발루맙 평가 연구(ROSETTA Lung-201)
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
리드: BMS · 협력: 바이오엔테크
- 1/2상모집 중· Hepatocellular Carcinoma (HCC)1차 진행성 또는 절제 불가능한 간세포암종 환자에서 푸미타미그 단독 또는 이필리무맙 병용의 안전성 및 내약성 평가(ROSETTA HCC-206)
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
리드: BMS · 협력: 바이오엔테크
- 2/3상모집 중· Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma미치료 진행성 또는 전이성 위선암·위식도접합부선암·식도선암 환자에서 Pumitamig 병용 화학요법 대 Nivolumab 병용 화학요법의 안전성 및 유효성 평가(ROSETTA Gastric-204)
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
리드: BMS · 협력: 바이오엔테크
- 3상모집 중· Non-Small Cell Lung Cancer (NSCLC)미치료 진행성 비소세포폐암 및 PD-L1 ≥ 50% 환자에서 Pumitamig 대 Pembrolizumab의 유효성 평가(ROSETTA Lung-202)
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
리드: BMS · 협력: 바이오엔테크
- 2상모집 중· Mpox (Monkeypox)아프리카에서 mRNA 기반 원숭이두창 백신 후보 접종 후 안전성, 반응원성, 면역원성을 조사하는 무작위 임상시험
A Randomized Clinical Trial Investigating the Safety, Reactogenicity, and Immunogenicity After Immunization With an mRNA-based Mpox Vaccine Candidate in Africa
리드: 바이오엔테크
- 1상모집 중· HIV -1 InfectionHIV 감염 및 비감염 성인에서 항체 BNT351의 안전성과 생물학적 활성을 조사하는 임상시험
A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIV
리드: 바이오엔테크
- 2상모집 중· Recurrent GlioblastomaA Clinical Trial Testing the Safety of the Investigational Drug Pumitamig (BNT327) and How Well it Works in Patients With Recurrent Glioblastoma
리드: 바이오엔테크 · 협력: BMS
- 2/3상모집 중· Untreated, Unresectable, or Metastatic Colorectal CancerA Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
리드: BMS · 협력: 바이오엔테크
- 2상모집 중· Pancreatic Ductal Adenocarcinoma (PDAC)A Clinical Trial Testing the Safety of Pumitamig (an Investigational Drug) and How Well it Works When Combined With Chemotherapy for People Who Have Not Been Treated Yet for Pancreatic Cancer
리드: 바이오엔테크 · 협력: BMS
- 3상모집 중· Breast NeoplasmsROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
리드: 바이오엔테크 · 협력: BMS
- 2상모집 중· CRC (Colorectal Cancer)PM8002 (BNT327) in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer
협력: 바이오엔테크
- 2상모집 중· Solid TumorsDB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
협력: 바이오엔테크
- 1/2상모집 중· Locally Advanced Breast CancerA Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
리드: 바이오엔테크
- 3상모집 중· Extensive-stage Small-cell Lung CancerSafety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
리드: 바이오엔테크 · 협력: BMS
- 1/2상모집 중· Advanced Solid TumorSafety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors
리드: 바이오엔테크
- 2/3상모집 중· Non-small Cell Lung CancerSafety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
리드: 바이오엔테크 · 협력: BMS
- 1/2상모집 중· Advanced Solid TumorsA Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
협력: 바이오엔테크
- 1/2상모집 중· HER2-positive Advanced Solid TumorA Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
협력: 바이오엔테크
- 1상모집 중· Lymphocytic LeukemiaA Personalized Neoantigen Cancer Vaccine in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated CLL.
협력: 바이오엔테크, 머크(MSD)
- 1/2상모집 중· Malignant NeoplasmPM8002 in the Treatment of Patients With Advanced Solid Tumors
협력: 바이오엔테크
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.